Innovation
Technology Concept
Technology Concept

Since the birth of gene sequencing technology in the 1970s, the rapid evolution of technology and the commercialization of sequencing instruments have been accelerating humanity's understanding of life sciences. Currently, human genome sequencing and analysis can be completed in as little as 8 hours, advancing at a pace exceeding "Moore's Law" and rapidly integrating into the trends of the information age.


We are not only witnesses to this technological wave but also drivers of the fourth-generation gene sequencing technology!


The fourth generation is defined by long-read single-molecule nanopore sequencing technology. Leveraging CMOS chip electric signal detection, we strive to achieve a highly accessible, cost-effective, and ultra-high-precision high-throughput nanopore single-molecule long-read gene sequencing solution, making sequencing technology more accessible.
 

Core Technology
Exclusive Bio-CMOS Sequencing Chip
Featuring the world's highest density integrated circuit nanopore sequencing chip, with millions of sequencing channels on a single chip, which lead to cost-effective, ultra-high throughput data output.
Advanced Synthetic Biology and Chemical Engineering
Equipped with state-of-the-art synthesis and analytical tools, help to enhance the signal-to-noise ratio in sequencing applications, improving data quality.
Breakthrough Electrochemical and Microfluidic Integration
enables ultra-low-cost instruments and test kits, high-density detection arrays with unparalleled sensitivity, accuracy, and speed.
Innovative AI-Driven
Drive advancements across multiple areas of our platform, including enzyme screening and engineering, product design and optimization, as well as data and bioinformatics analysis.
Innovation Results
Innovation Results

AXBIO, rooted in the high-tech industry, places great emphasis on independent product research and development. While establishing an independent innovation technology system, we have harvested abundant technological achievements. To date, we owned an aggregate of 33 issued invention patents, as well as 17 software copyrights and four layout-design of integrated circuits, which collectively safeguard our
proprietary products and technologies.

50+Global Patent Authorization

Copyright ©Axbio Inc. All rights reserved.